sign up log in
Want to go ad-free? Find out how, here.

EBO - Ebos Group profile

This is a basic profile of an NZX50 listed company. It is not investment advice. We recommend you contact a qualified adviser if you need more information.

Ebos Group 


NZX code: EBO
Short name: Ebos
Legal name: Ebos Group Limited
Industry sector: Healthcare equpiment
NZX50 rank: 6 of 50
Head office address: 108 Wrights Road, Christchurch, Auckland
Chairman: Elizabeth Coutts
Chief executive: John Cullity
Financial year ended: June
Locations: New Zealand, Australia
Auditor: Deloitte
Bankers: [not revealed]

[back to full list]

EBOS Group

Select chart tabs

EBO capitalisation
EBO rank in NZX50
EBO share price
EBO % change to capitalisation
EBO $mln change to capitalisation

Financial statement history

A. Recent trading and performance summary:

NPAT Dividend
per share
fye June bln mln cents
2018 $7.609 $152 68.5
2019 $6.930 $137 71.5
2020 $8.766 $162 77.5
2021 $9.203 $184 88.5
2022 $10.734 $202 96.0
2023 $12.237 $263 110.0

[back to full list]

B. Recent financial position summary:

fye June bln bln %
2018 $3.26 $2.04 37.4
2019 $3.20 $1.96 38.8
2020 $3.75 $2.44 34.9
2021 $3.95 $2.54 35.7
2022 $6.26 $4.11 34.3
2023 $6.44 $4.13 35.9

[back to full list]

C. Recent cash flows and positions:

Cash and equiv. 
at year end
fye June mln mln mln
2018 $176.2 $181.1 $163.3
2019 $134.9 $120.1 $166.6
2020 $229.2 $148.1 $244.8
2021 $298.3 $373.7 $169.0
2022 $1750.4 $1396.2 $517.3
2023 $938.5 $154.3 $211.9

[back to full list]

D. Recent key ratio analysis:

per share
NTA/share Dividend
fye June cents annual avg dollars annual avg %
2018 90.4 19.9 (0.01) 3.82
2019 89.8 25.8 0.80 3.09
2020 100.6 21.5 1.08 3.59
2021 113.2 28.5 0.14 2.74
2022 114.5 35.0 (2.70) 2.46

[back to full list]


Description of trading activities 

"EBOS Group is the largest and most diversified Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. It is also a leading marketer and distributor of recognised consumer products and animal care brands.” In the healthcare sector, EBOS Group Limited is involved in; community pharmacy, Institutional healthcare, consumer products and contract logistics, with the majority of companies under the former three sectors.

[back to full list]

CEO profile

John Cullity has been the CEO of Ebos since April 2018. Cullity was previously the CFO of EBOS from the 1st July 2014 and was promoted to CEO after Patrick Davies stepped down. Cullity has more than 25 years’ of experience in senior management roles and has worked in other publicly listed Australian companies and the United States. Cullity has a Bachelor of Economics from Monash University and is a member of Chartered Accountants Australia and New Zealand.

Chairman profile

Elizabeth Coutts was appointed to the EBOS Group Limited Board in July 2003. Coutts is Chairman of the Remuneration Committee and a member of the Audit and Risk Committee. Coutts us also Chair of Ports of Auckland Ltd, Urwin & Co Limited, Oceania Healthcare Ltd and Skellerup Holdings Limited and Director of EBOS Group subsidiaries in New Zealand and Member, Marsh New Zealand Advisory Board.


Company website:
Investor information:
NZX listing:
Annual reports:

[back to full list]